116 related articles for article (PubMed ID: 10941806)
21. Quantitative differences in CD8+ lymphocytes, CD4/CD8 ratio, NK cells, and HLA-DR(+)-activated T cells of racially different male populations.
Shahabuddin S
Clin Immunol Immunopathol; 1995 May; 75(2):168-70. PubMed ID: 7704975
[TBL] [Abstract][Full Text] [Related]
22. Anti-dsDNA production coincides with concurrent B and T cell activation during development of active disease in systemic lupus erythematosus (SLE).
Spronk PE; Horst G; Van Der Gun BT; Limburg PC; Kallenberg CG
Clin Exp Immunol; 1996 Jun; 104(3):446-53. PubMed ID: 9099929
[TBL] [Abstract][Full Text] [Related]
23. CD45 isoforms expression on CD4+ and CD8+ peripheral blood T-lymphocytes is related to auto-immune processes and hematological manifestations in systemic lupus erythematosus.
Neidhart M; Pataki F; Michel BA; Fehr K
Schweiz Med Wochenschr; 1996 Nov; 126(45):1922-5. PubMed ID: 8946597
[TBL] [Abstract][Full Text] [Related]
24. The expression of human leukocyte antigen-DR and CD25 on circulating T cells in cutaneous lupus erythematosus and correlation with disease activity.
Wenzel J; Henze S; Brähler S; Bieber T; Tüting T
Exp Dermatol; 2005 Jun; 14(6):454-9. PubMed ID: 15885081
[TBL] [Abstract][Full Text] [Related]
25. HLA-DR expression on lymphocyte subsets as a marker of disease activity in patients with systemic lupus erythematosus.
Viallard JF; Bloch-Michel C; Neau-Cransac M; Taupin JL; Garrigue S; Miossec V; Mercie P; Pellegrin JL; Moreau JF
Clin Exp Immunol; 2001 Sep; 125(3):485-91. PubMed ID: 11531958
[TBL] [Abstract][Full Text] [Related]
26. Do elevated levels of serum-soluble fas contribute to the persistence of activated lymphocytes in systemic lupus erythematosus?
Bijl M; van Lopik T; Limburg PC; Spronk PE; Jaegers SM; Aarden LA; Smeenk RJ; Kallenberg GG
J Autoimmun; 1998 Oct; 11(5):457-63. PubMed ID: 9802929
[TBL] [Abstract][Full Text] [Related]
27. Increased expression of activation antigens on CD8+ T lymphocytes in Myalgic Encephalomyelitis/chronic fatigue syndrome: inverse associations with lowered CD19+ expression and CD4+/CD8+ ratio, but no associations with (auto)immune, leaky gut, oxidative and nitrosative stress biomarkers.
Maes M; Bosmans E; Kubera M
Neuro Endocrinol Lett; 2015; 36(5):439-46. PubMed ID: 26707044
[TBL] [Abstract][Full Text] [Related]
28. CD4+CD25+ regulatory T cells (TREG) in systemic lupus erythematosus (SLE) patients: the possible influence of treatment with corticosteroids.
Azab NA; Bassyouni IH; Emad Y; Abd El-Wahab GA; Hamdy G; Mashahit MA
Clin Immunol; 2008 May; 127(2):151-7. PubMed ID: 18299252
[TBL] [Abstract][Full Text] [Related]
29. Participation of the CD69 antigen in the T-cell activation process of patients with systemic lupus erythematosus.
Crispin JC; Martínez A; de Pablo P; Velasquillo C; Alcocer-Varela J
Scand J Immunol; 1998 Aug; 48(2):196-200. PubMed ID: 9716112
[TBL] [Abstract][Full Text] [Related]
30. Concentration of activated T lymphocytes in extracorporeal blood circulation for plasma separation.
Ijichi S; Mishima M; Matsuda T; Izumihara T; Kojima K; Niimura T; Maruyama I; Osame M
J Clin Apher; 1991; 6(2):88-9. PubMed ID: 1938996
[TBL] [Abstract][Full Text] [Related]
31. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
[TBL] [Abstract][Full Text] [Related]
32. [Proliferation of large granular lymphocytes in patients with systemic lupus erythematosus].
Sampalo Lainz A; López-Gómez M; Jiménez-Alonso J
Rev Clin Esp; 1995 Jun; 195(6):373-9. PubMed ID: 7644784
[TBL] [Abstract][Full Text] [Related]
33. Effect of intravenous cyclophosphamide in systemic lupus erythematosus: relation to lymphocyte subsets and activation markers.
Amano H; Morimoto S; Kaneko H; Tokano Y; Takasaki Y; Hashimoto H
Lupus; 2000; 9(1):26-32. PubMed ID: 10713644
[TBL] [Abstract][Full Text] [Related]
34. Characterization of CD3+ CD4- CD8- (double negative) T cells in patients with systemic lupus erythematosus: production of IL-4.
Dean GS; Anand A; Blofeld A; Isenberg DA; Lydyard PM
Lupus; 2002; 11(8):501-7. PubMed ID: 12220104
[TBL] [Abstract][Full Text] [Related]
35. Activated T lymphocytes in the peripheral blood of patients with systemic lupus erythematosus induce B cells to produce immunoglobulin.
Inghirami G; Simon J; Balow JE; Tsokos GC
Clin Exp Rheumatol; 1988; 6(3):269-76. PubMed ID: 3263240
[TBL] [Abstract][Full Text] [Related]
36. [Activation of T lymphocytes and severity of atopic bronchial asthma in children].
Bartkowiak M; Kołecki P; Alkiewicz J
Pneumonol Alergol Pol; 1995; 63(9-10):490-7. PubMed ID: 8620168
[TBL] [Abstract][Full Text] [Related]
37. The abnormal apoptosis of T cell subsets and possible involvement of IL-10 in systemic lupus erythematosus.
Wang H; Xu J; Ji X; Yang X; Sun K; Liu X; Shen Y
Cell Immunol; 2005 Jun; 235(2):117-21. PubMed ID: 16226734
[TBL] [Abstract][Full Text] [Related]
38. HLA-DP-positive T cells in patients with systemic lupus erythematosus.
Tokano Y; Hishikawa T; Hirose T; Sekigawa I; Hashimoto H; Okumura K; Hirose S
Autoimmunity; 1990; 5(3):179-83. PubMed ID: 2129750
[TBL] [Abstract][Full Text] [Related]
39. Clinical amelioration of murine lupus by a peptide based on the complementarity determining region-1 of an autoantibody and by cyclophosphamide: similarities and differences in the mechanisms of action.
Sharabi A; Azulai H; Sthoeger ZM; Mozes E
Immunology; 2007 Jun; 121(2):248-57. PubMed ID: 17346282
[TBL] [Abstract][Full Text] [Related]
40. Upregulated IL-1 Receptor-associated Kinase 1 (IRAK1) in Systemic Lupus Erythematosus: IRAK1 Inhibition Represses Th17 Differentiation with Therapeutic Potential.
Zhou Z; Tian Z; Zhang M; Zhang Y; Ni B; Hao F
Immunol Invest; 2018 Jul; 47(5):468-483. PubMed ID: 29611775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
